J9171 HCPCS code: Injection, docetaxel, 1 mg
J9171 is the HCPCS Level II code for injection, docetaxel, 1 mg. In 2024 Medicare paid an average of $0.68 per service for J9171 across 3,891,468 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 300 per day on DME suppliers. Medicare volume fell 10% from 2022 to 2024 (4,339,241 to 3,891,468 services). In 2024, about 4,483 clinicians billed Medicare for J9171 for 9,100 beneficiaries; Texas, Florida, California accounted for 34% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2010-01-01 |
| Last action effective | 2024-01-01 |
Who bills J9171 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 4,483 |
| Medicare beneficiaries | 9,100 |
| States with claims | 46 |
| Share of services in top 3 states (Texas, Florida, California) | 34% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9171, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 4,339,241 | 9,481 | $0.47 | $0.37 |
| 2023 | 4,340,503 | 9,562 | $0.67 | $0.53 |
| 2024 | 3,891,468 | 9,100 | $0.86 | $0.68 |
States with the most J9171 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 460,374 | $0.68 |
| Florida | 459,640 | $0.69 |
| California | 392,850 | $0.69 |
| Illinois | 208,306 | $0.67 |
| Virginia | 165,213 | $0.69 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 300 | Prescribing Information |
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J9171
- 2010-01-01: J9171 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9171?
J9171 is the HCPCS Level II code for injection, docetaxel, 1 mg. Short descriptor: "Docetaxel injection".
How much does Medicare pay for J9171?
In 2024, the average Medicare payment was $0.68 per service (average allowed $0.86).
Does Medicare cover J9171?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J9171 can be billed per day?
300 on DME suppliers; 300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9171
- Watch J9171 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9171
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.